NEW YORK, NY / ACCESSWIRE / February 1, 2022 / Jakubowitz Law announces that securities fraud class action lawsuits have commenced on behalf of shareholders of the following publicly-traded companies who purchased shares within the class periods listed below. Shareholders interested in representing the class of wronged shareholders have until the lead plaintiff deadline to petition the court. Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff. For more details and to speak with our firm without cost or obligation, follow the links below.
Cloopen Group Holding Limited (NYSE:RAAS)
CONTACT JAKUBOWITZ ABOUT RAAS:
https://claimyourloss.com/securities/cloopen-group-holding-limited-loss-submission-form/?id=22785&from=1
This lawsuit is on behalf of all persons who: (a) purchased or otherwise acquired Cloopen American Depositary Shares pursuant and/or traceable to the Company’s February 2021 initial public offering; and/or (b) purchased or otherwise acquired Cloopen securities between February 9, 2021 and May 10, 2021.
Lead Plaintiff Deadline : February 8, 2022
The filed complaint alleges that defendants made materially false and/or misleading statements and/or failed to disclose that: an increasing number of Cloopen customers were refusing to pay, forcing the Company to record massive increases in its accounts receivables and allowance for doubtful accounts. The documents issued in connection with the Company’s initial public offering also failed to disclose that Cloopen was weighted down by massive liabilities related to the fair value of certain recently-granted warrants.
Robinhood Markets, Inc. (NASDAQ:HOOD)
CONTACT JAKUBOWITZ ABOUT HOOD:
https://claimyourloss.com/securities/robinhood-markets-inc-loss-submission-form/?id=22785&from=1
This lawsuit is on behalf of persons and entities that purchased or otherwise acquired Robinhood shares pursuant and/or traceable to the Company’s initial public offering conducted in July 2021.
Lead Plaintiff Deadline : February 15, 2022
According to the filed complaint, documents that the Company issued in connection with its IPO contained representations that were materially inaccurate, misleading, and/or incomplete because they failed to disclose that, at the time of the IPO, Robinhood’s revenue growth was experiencing a major reversal, with transaction-based revenues from cryptocurrency trading serving only as a short-term, transitory injection, masking what was actually stagnating growth. In addition, the Company’s “significant investments” in enhancing the reliability and scalability of its platform were patently inadequate and/or defective, exposing Robinhood to worsening service-level disruptions and security breaches, particularly as the Company scaled its services to a larger user base.
Reata Pharmaceuticals, Inc. (NASDAQ:RETA)
CONTACT JAKUBOWITZ ABOUT RETA:
https://claimyourloss.com/securities/reata-pharmaceuticals-inc-loss-submission-form-2/?id=22785&from=1
This lawsuit is on behalf of persons and entities that purchased or otherwise acquired Reata securities, and/or sold Reata put options, between November 9, 2020 and December 8, 2021, inclusive.
Lead Plaintiff Deadline : February 18, 2022
The filed complaint alleges that defendants made materially false and/or misleading statements and/or failed to disclose that: (1) the Food and Drug Administration had raised concerns regarding the validity of the clinical study designed to measure the efficacy and safety of bardoxolone for the treatment of chronic kidney disease caused by Alport syndrome; (2) as a result, there was a material risk that Reata’s New Drug Application would not be approved; and (3) as a result of the foregoing, defendants’ positive statements about the Company’s business, operations, and prospects were materially misleading and/or lacked a reasonable basis.
Jakubowitz Law is vigorous in pursuit of justice for shareholders who have been the victim of securities fraud. Attorney advertising. Prior results do not guarantee similar outcomes.
CONTACT:
JAKUBOWITZ LAW
1140 Avenue of the Americas
9th Floor
New York, New York 10036
T: (212) 867-4490
F: (212) 537-5887
SOURCE: Jakubowitz Law
View source version on accesswire.com:
https://www.accesswire.com/686870/Lawsuits-Filed-Against-RAAS-HOOD-and-RETA-Jakubowitz-Law-Pursues-Shareholders-Claims
